The move highlights Huawei's ambitions to gain a foothold in the fast-growing AI drug discovery market, where pharmaceutical companies are investing in modelling tools and automated laboratories to shorten development timelines and improve efficiency.

SHANGHAI, Aug 27 : Chinese technology conglomerate Huawei plans to expand its AI cooperation with local pharmaceutical firms into drug development and clinical practice, a senior…

The move highlights Huawei's ambitions to gain a foothold in the fast-growing AI drug discovery market, where pharmaceutical companies are investing in modelling tools and…